Digital Ally Inc.Announces Adjournment of Special Meeting

Lenexa, KS, December 27, 2021 (GLOBE NEWSWIRE) – Digital Ally, Inc. (NASDAQ: DGLY) (the “Society“), announced today that the special meeting of shareholders scheduled for December 28, 2021 (the “Special Meeting”) has been adjourned until Tuesday, January 11, 2022 at 11:15 am (Eastern Time) without any transactions.

The Company has adjourned the Annual Meeting in order to allow it sufficient time to achieve a quorum for the conduct of business under the Amended and Restated Articles of the Company. The registration date for the adjourned special meeting remains the close of business on October 21, 2021. Shareholders who have already voted do not need to vote again, unless they wish to change their vote. Previously submitted proxies will be voted on at the new meeting, unless they are properly revoked. Shareholders who did not vote or who wish to change their vote are encouraged to do so by promptly using the instructions provided on their voting instruction form or proxy card.

The vote of each shareholder counts and is important regardless of the number of shares they own. The Company urges all shareholders to take the time to read and respond to the Company’s proxy documents previously provided to them and to vote on their shares immediately to ensure that their votes count on time to the date of l Special meeting adjourned.

To vote by telephone or deliver electronically, shareholders must have their proxy control number. This number is either printed on the voting instruction form, if the shareholders have received a physical copy of the proxy documents, or accessible through the voting portal, if the proxy documents have been transmitted electronically. Shareholders who have sold their shares but who were holders of record at the close of business on October 21, 2021, the reference date for the extraordinary meeting, retain the right to vote. The Company encourages its shareholders who have already voted against one of the proposals in the definitive proxy statement for the extraordinary meeting (the “proxy statement”) to reconsider their vote. In particular, the Board of Directors of the Company encourages shareholders to vote “FOR” each of the proposals described in the Proxy Circular.

Shareholders who need help submitting their proxy or voting for their shares should call the company’s attorney, Laurel Hill Advisory Group. Additionally, if you have any questions or need help voting for your shares, please contact Laurel Hill below:

Laurel Hill LLC Advisory Group
Call Toll Free for Shareholders: (888) 742-1305

About Digital Ally

Digital Ally, Inc., through its subsidiaries, is engaged in vehicle and body cameras, flexible software storage, automatic recording technology and various critical security products; Shield^™ A range of health protection products, including all natural cleansers, a non-contact temperature control device, an electrostatic sprayer and a variety of personal protective equipment. With the recent creation of Digital Ally Healthcare, Inc., a medical records company and the acquisition of TicketSmarter^®, LLC, a national ticket broker, Digital Ally continues to add organizations that demonstrate the common traits of positive earnings, growth potential and organizational synergies.

For news and additional information, please visit www.digitalallyinc.com or follow Digital Ally Inc.’s other social media channels here:

Facebook | Instagram | LinkedIn | Twitter

Contact details
Stanton Ross, CEO
Tom Heckman, Chief Financial Officer
Digital Ally, Inc.
913-814-7774
info@digitalallyinc.com

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current expectations as of the date of this press release and involve certain risks and uncertainties. Forward-looking statements include statements herein regarding the successful execution of the Company’s business strategy. The actual results of the Company could differ materially from those anticipated in these forward-looking statements due to various factors. These risks and uncertainties include, among others, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to potentially license other patents and patent applications necessary for development. of products ; the availability of funding; the Company’s ability to implement its long-term business plan for various applications of its technology; the Company’s ability to enter into agreements with all necessary marketing and / or distribution partners; the impact of competition, obtaining and maintaining all necessary regulatory approvals applicable to the applications of the Company’s technology; the inability to find and complete strategic acquisitions; the impact of the COVID-19 pandemic; and the management of growth and other risks and uncertainties as may be detailed from time to time in the Company’s reports filed with the Securities and Exchange Commission.

* * *

Note: Notwithstanding the foregoing or any provision to the contrary contained herein, as a precautionary measure due to the coronavirus epidemic (COVID-19), the Company anticipates the possibility that there may be limitations on participation in the extraordinary meeting in person, or the Company may decide to hold the Special Meeting on a different date, in a different location or by means of remote communication (ie a “virtual meeting”).